JP2005508165A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005508165A5 JP2005508165A5 JP2003534444A JP2003534444A JP2005508165A5 JP 2005508165 A5 JP2005508165 A5 JP 2005508165A5 JP 2003534444 A JP2003534444 A JP 2003534444A JP 2003534444 A JP2003534444 A JP 2003534444A JP 2005508165 A5 JP2005508165 A5 JP 2005508165A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- seq
- amino acids
- polynucleotide
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920001184 polypeptide Polymers 0.000 claims 96
- 108090000765 processed proteins & peptides Proteins 0.000 claims 96
- 102000004196 processed proteins & peptides Human genes 0.000 claims 96
- 150000001413 amino acids Chemical class 0.000 claims 95
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 58
- 102000040430 polynucleotide Human genes 0.000 claims 41
- 108091033319 polynucleotide Proteins 0.000 claims 41
- 239000002157 polynucleotide Substances 0.000 claims 41
- 230000014511 neuron projection development Effects 0.000 claims 24
- 102000005781 Nogo Receptor Human genes 0.000 claims 22
- 108020003872 Nogo receptor Proteins 0.000 claims 22
- 230000001404 mediated effect Effects 0.000 claims 22
- 230000005764 inhibitory process Effects 0.000 claims 19
- 239000012634 fragment Substances 0.000 claims 11
- 239000000203 mixture Substances 0.000 claims 10
- 150000007523 nucleic acids Chemical class 0.000 claims 10
- 210000004027 cell Anatomy 0.000 claims 7
- 102000039446 nucleic acids Human genes 0.000 claims 7
- 108020004707 nucleic acids Proteins 0.000 claims 7
- 102000002260 Alkaline Phosphatase Human genes 0.000 claims 4
- 108020004774 Alkaline Phosphatase Proteins 0.000 claims 4
- 102000005720 Glutathione transferase Human genes 0.000 claims 4
- 108010070675 Glutathione transferase Proteins 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 238000000034 method Methods 0.000 claims 4
- 208000016192 Demyelinating disease Diseases 0.000 claims 3
- 241000124008 Mammalia Species 0.000 claims 3
- 206010052428 Wound Diseases 0.000 claims 3
- 208000027418 Wounds and injury Diseases 0.000 claims 3
- 230000003376 axonal effect Effects 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 230000002401 inhibitory effect Effects 0.000 claims 3
- 210000002569 neuron Anatomy 0.000 claims 3
- 230000008929 regeneration Effects 0.000 claims 3
- 238000011069 regeneration method Methods 0.000 claims 3
- -1 antibody Substances 0.000 claims 2
- 210000003169 central nervous system Anatomy 0.000 claims 2
- 230000002490 cerebral effect Effects 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000035475 disorder Diseases 0.000 claims 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims 2
- 238000000338 in vitro Methods 0.000 claims 2
- 238000002360 preparation method Methods 0.000 claims 2
- 230000001737 promoting effect Effects 0.000 claims 2
- 238000006467 substitution reaction Methods 0.000 claims 2
- 208000011403 Alexander disease Diseases 0.000 claims 1
- 206010003694 Atrophy Diseases 0.000 claims 1
- 208000022526 Canavan disease Diseases 0.000 claims 1
- 206010012305 Demyelination Diseases 0.000 claims 1
- 208000010055 Globoid Cell Leukodystrophy Diseases 0.000 claims 1
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 claims 1
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 claims 1
- 208000028226 Krabbe disease Diseases 0.000 claims 1
- 208000034800 Leukoencephalopathies Diseases 0.000 claims 1
- 102100026784 Myelin proteolipid protein Human genes 0.000 claims 1
- 206010056332 Panencephalitis Diseases 0.000 claims 1
- 208000017493 Pelizaeus-Merzbacher disease Diseases 0.000 claims 1
- 102100029826 Reticulon-4 receptor Human genes 0.000 claims 1
- 230000001919 adrenal effect Effects 0.000 claims 1
- 239000000427 antigen Substances 0.000 claims 1
- 102000036639 antigens Human genes 0.000 claims 1
- 108091007433 antigens Proteins 0.000 claims 1
- 230000037444 atrophy Effects 0.000 claims 1
- 208000015114 central nervous system disease Diseases 0.000 claims 1
- 230000007850 degeneration Effects 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 201000002491 encephalomyelitis Diseases 0.000 claims 1
- 210000003527 eukaryotic cell Anatomy 0.000 claims 1
- 208000014674 injury Diseases 0.000 claims 1
- 238000007918 intramuscular administration Methods 0.000 claims 1
- 238000007912 intraperitoneal administration Methods 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- 208000036546 leukodystrophy Diseases 0.000 claims 1
- 230000003458 metachromatic effect Effects 0.000 claims 1
- 238000000520 microinjection Methods 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 230000023105 myelination Effects 0.000 claims 1
- 238000007911 parenteral administration Methods 0.000 claims 1
- 210000000278 spinal cord Anatomy 0.000 claims 1
- 208000023516 stroke disease Diseases 0.000 claims 1
- 238000007920 subcutaneous administration Methods 0.000 claims 1
- 230000008733 trauma Effects 0.000 claims 1
- 210000004885 white matter Anatomy 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/972,599 US7119165B2 (en) | 2000-01-12 | 2001-10-06 | Nogo receptor-mediated blockade of axonal growth |
| PCT/US2002/032007 WO2003031462A2 (en) | 2001-10-06 | 2002-10-04 | Nogo receptor-mediated blockade of axonal growth |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005508165A JP2005508165A (ja) | 2005-03-31 |
| JP2005508165A5 true JP2005508165A5 (https=) | 2006-01-05 |
| JP4383869B2 JP4383869B2 (ja) | 2009-12-16 |
Family
ID=25519870
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003534444A Expired - Fee Related JP4383869B2 (ja) | 2001-10-06 | 2002-10-04 | 軸索成長のnogoのレセプターを仲介とした妨害 |
Country Status (6)
| Country | Link |
|---|---|
| US (6) | US7119165B2 (https=) |
| EP (1) | EP1451337A4 (https=) |
| JP (1) | JP4383869B2 (https=) |
| AU (1) | AU2002334889B2 (https=) |
| CA (1) | CA2461655A1 (https=) |
| WO (1) | WO2003031462A2 (https=) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002522016A (ja) * | 1998-07-22 | 2002-07-23 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | 神経内分泌特異的タンパク質に類似したタンパク質、およびそれをコードするcDNA |
| US7119165B2 (en) * | 2000-01-12 | 2006-10-10 | Yale University | Nogo receptor-mediated blockade of axonal growth |
| DE60141409D1 (de) * | 2000-10-06 | 2010-04-08 | Biogen Idec Inc | Homologe des nogo rezeptors |
| US7309485B2 (en) * | 2001-12-03 | 2007-12-18 | Children's Medical Center Corporation | Reducing myelin-mediated inhibition of axon regeneration |
| US7745151B2 (en) * | 2002-08-02 | 2010-06-29 | Children's Medical Center Corporation | Methods of determining binding between Nogo receptor and p75 neurotrophin receptor |
| ES2346868T3 (es) * | 2002-08-10 | 2010-10-21 | Yale University | Antagonistas de receptor nogo. |
| US7408028B2 (en) * | 2002-12-06 | 2008-08-05 | Sinapore General Hospital Pte Ltd. | Peptides, antibodies thereto, and their use in treatment of central nervous system, damage |
| US7842666B2 (en) * | 2002-12-20 | 2010-11-30 | Research Foundation Of City University Of New York | Inhibitors of myelin-associated glycoprotein (MAG) activity for regulating neural growth and regeneration |
| CA2519227C (en) | 2003-03-19 | 2013-12-03 | Biogen Idec Ma Inc. | Nogo receptor binding protein |
| US7541335B2 (en) * | 2003-04-04 | 2009-06-02 | University Of Rochester | Nogo-receptors and methods of use |
| EA009643B1 (ru) * | 2003-04-16 | 2008-02-28 | Йейл Юниверсити | Лечение состояний, включающих амилоидные бляшки |
| JP2007537985A (ja) * | 2003-05-15 | 2007-12-27 | ザ ボード オブ トラスティーズ オブ ザ リランド スタンフォード ジュニア ユニバーシティー | 免疫調節ペプチド |
| US20080274112A1 (en) * | 2003-08-07 | 2008-11-06 | Lee Daniel H S | Nogo Receptor Antagonists |
| US8912144B2 (en) * | 2003-12-16 | 2014-12-16 | Children's Medical Center Corporation | Method for treating stroke via administration of NEP1-40 and inosine |
| US20080274077A1 (en) * | 2003-12-16 | 2008-11-06 | Children's Medical Center Corporation | Method for Treating Neurological Disorders |
| KR20070052237A (ko) * | 2004-01-30 | 2007-05-21 | 비오겐 아이덱 엠에이 아이엔씨. | 노고 수용체 길항제를 사용한, 도파민성 신경 퇴행을수반하는 상태의 치료법 |
| DK1773872T3 (en) * | 2004-05-21 | 2017-05-08 | Uab Res Found | VARIABLE Lymphocyte Receptors, Associated Polypeptides and Nucleic Acids, and Uses thereof |
| US8486893B2 (en) * | 2004-06-24 | 2013-07-16 | Biogen Idec Ma Inc. | Treatment of conditions involving demyelination |
| EP1789070B1 (en) | 2004-08-03 | 2012-10-24 | Biogen Idec MA Inc. | Taj in neuronal function |
| EP1805209A4 (en) * | 2004-10-01 | 2008-04-02 | Univ Yale | NOGO-A POLYPEPTIDE FRAGMENTS, VARIANT OF NOGO RECEPTOR-1 POLYPEPTIDES AND USE |
| WO2006056998A2 (en) * | 2004-11-29 | 2006-06-01 | Yeda Research And Development Co. Ltd. | Methods of cell therapy, neurogenesis and oligodendrogenesis |
| WO2007008732A2 (en) * | 2005-07-07 | 2007-01-18 | Yale University | Compositions and methods for suppressing axonal growth inhibition |
| HRP20131066T1 (hr) | 2005-07-08 | 2013-12-06 | Biogen Idec Ma Inc. | Sp35 antitijela i njihova upotreba |
| WO2007014382A1 (en) * | 2005-07-28 | 2007-02-01 | Wyeth | Compositions and methods of mutant nogo-66 domain proteins |
| US7951384B2 (en) * | 2005-08-05 | 2011-05-31 | University Of Massachusetts | Virus-like particles as vaccines for paramyxovirus |
| US9216212B2 (en) | 2005-08-05 | 2015-12-22 | University Of Massachusetts | Virus-like particles as vaccines for paramyxovirus |
| US20090062199A1 (en) * | 2005-08-25 | 2009-03-05 | Biogen Idec Ma Inc. | Nogo Receptor Polypeptides and Polypeptide Fragments and Uses Thereof |
| EP1928905B1 (de) * | 2005-09-30 | 2015-04-15 | AbbVie Deutschland GmbH & Co KG | Bindungsdomänen von proteinen der repulsive guidance molecule (rgm) proteinfamilie und funktionale fragmente davon sowie deren verwendung |
| PT1981902E (pt) | 2006-01-27 | 2015-11-02 | Biogen Ma Inc | Antagonistas dos recetores nogo |
| US20110123535A1 (en) * | 2006-05-15 | 2011-05-26 | Biogen Idec Ma Inc. | Use of Nogo Receptor-1 (NGR1) for Promoting Oligodendrocyte Survival |
| US20080027001A1 (en) * | 2006-07-07 | 2008-01-31 | Andrew Wood | Nogo receptor functional motifs, peptide mimetics, and mutated functional motifs related thereto, and methods of using the same |
| EP2068866A4 (en) | 2006-07-24 | 2010-04-07 | Biogen Idec Inc | METHODS FOR PROMOTING MYELINIZATION, NEURONAL SURVIVAL AND DIFFERENTIATION OF OLIGODENDROCYTES BY ADMINISTERING SP35 OR TRKA ANTAGONISTS |
| EP2081429A4 (en) * | 2006-08-31 | 2010-01-06 | Biogen Idec Inc | PROCESS FOR PERIPHERAL ADMINISTRATION OF NOGO RECEPTOR POLYPEPTIDES |
| WO2009048605A1 (en) * | 2007-10-11 | 2009-04-16 | Biogen Idec Ma Inc. | Methods for treating pressure induced optic neuropathy, preventing neuronal degeneration and promoting neuronal cell, survival via administration of lingo-1 antagonists and trkb agonists |
| WO2009061500A1 (en) * | 2007-11-08 | 2009-05-14 | Biogen Idec Ma Inc. | Use of lingo-4 antagonists in the treatment of conditions involving demyelination |
| WO2009073141A2 (en) * | 2007-11-28 | 2009-06-11 | Strittmatter Stephen M | Nogo receptor binding small molecules to promote axonal growth |
| US8962803B2 (en) | 2008-02-29 | 2015-02-24 | AbbVie Deutschland GmbH & Co. KG | Antibodies against the RGM A protein and uses thereof |
| EP2276500A4 (en) * | 2008-03-13 | 2015-03-04 | Univ Yale | REACTIVATION OF AXON GROWTH AND AXON RECOVERY IN CHRONIC REVERSE MARKET INJURIES |
| CA2729961C (en) | 2008-07-09 | 2018-05-01 | Biogen Idec Ma Inc. | Li113, li62 variant co2, anti-lingo antibodies |
| US8580270B2 (en) | 2008-09-30 | 2013-11-12 | University Of Massachusetts | Respiratory synctial virus (RSV) sequences for protein expression and vaccines |
| MX2012006560A (es) | 2009-12-08 | 2012-10-05 | Abbott Gmbh & Co Kg | Anticuerpos monoclonales contra la proteina rgm a para utilizarse en el tratamiento de degeneracion de capa de fibra de nervio retinal. |
| EP3369746A1 (en) | 2012-01-27 | 2018-09-05 | AbbVie Deutschland GmbH & Co KG | Composition and method for diagnosis and treatment of diseases associated with neurite degeneration |
| KR102142161B1 (ko) | 2012-05-14 | 2020-08-06 | 바이오젠 엠에이 인코포레이티드 | 운동 뉴런 관련 병태 치료용 lingo-2 길항제 |
| JP2018504400A (ja) | 2015-01-08 | 2018-02-15 | バイオジェン・エムエイ・インコーポレイテッドBiogen MA Inc. | Lingo‐1拮抗薬及び脱髄障害の治療のための使用 |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1341050C (en) | 1988-11-04 | 2000-07-11 | Martin E. Schwab | Neurite growth regulatory factors |
| US5250414A (en) | 1988-11-04 | 1993-10-05 | Erziehungsdirektion Of The Canton Zurich | Diagnostic methods using neurite growth regulatory factors |
| EP0396719B1 (en) | 1988-11-04 | 1995-07-05 | Erziehungsdirektion Of The Canton Zurich | Neurite growth regulatory factors |
| WO2000073452A2 (en) | 1999-06-02 | 2000-12-07 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
| US5858708A (en) | 1996-08-12 | 1999-01-12 | Bandman; Olga | Polynucleotides encoding two novel human neuroendocrine-specific proteins |
| US7368531B2 (en) * | 1997-03-07 | 2008-05-06 | Human Genome Sciences, Inc. | Human secreted proteins |
| ES2312205T3 (es) | 1998-03-10 | 2009-02-16 | Genentech, Inc. | Nuevo polipeptido y acidos nucleicos que lo codifican. |
| US6962797B2 (en) * | 1998-04-15 | 2005-11-08 | Genentech, Inc. | Nucleic acids encoding PRO615 |
| CA2331154A1 (en) | 1998-06-16 | 1999-12-23 | Human Genome Sciences, Inc. | Polypeptides having sequence identity with acid labile subunit of insulin-like growth factor |
| JP2002522016A (ja) | 1998-07-22 | 2002-07-23 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | 神経内分泌特異的タンパク質に類似したタンパク質、およびそれをコードするcDNA |
| CN101684155A (zh) | 1998-11-06 | 2010-03-31 | 苏黎世大学 | Nogo基因的核苷酸序列和蛋白序列以及基于其的方法 |
| US6152155A (en) | 1998-11-30 | 2000-11-28 | Milligan; Lon | Filter cleaning device |
| JP3695642B2 (ja) | 1998-12-01 | 2005-09-14 | ジェネンテック・インコーポレーテッド | 血管形成及び心臓血管新生の促進又は阻害 |
| ES2327785T3 (es) | 1998-12-22 | 2009-11-03 | Genentech, Inc. | Procedimientos y compuestos para inhibir el crecimiento de celulas neoplasticas. |
| US7041474B2 (en) | 1998-12-30 | 2006-05-09 | Millennium Pharmaceuticals, Inc. | Nucleic acid encoding human tango 509 |
| CA2362427A1 (en) | 1999-03-08 | 2000-09-14 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
| EP1263948A2 (en) | 1999-03-08 | 2002-12-11 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| WO2000058473A2 (en) | 1999-03-31 | 2000-10-05 | Curagen Corporation | Nucleic acids including open reading frames encoding polypeptides; 'orfx' |
| AU3632600A (en) | 1999-05-14 | 2000-12-05 | Genentech Inc. | Compositions and methods for the treatment of immune related diseases |
| AU6394400A (en) | 1999-07-30 | 2001-02-19 | Millennium Pharmaceuticals, Inc. | Secreted proteins and uses thereof |
| HK1051543A1 (zh) | 2000-01-12 | 2003-08-08 | Yale University | Nogo受体介导的轴突生长封锁 |
| US7119165B2 (en) | 2000-01-12 | 2006-10-10 | Yale University | Nogo receptor-mediated blockade of axonal growth |
| DE60141409D1 (de) | 2000-10-06 | 2010-04-08 | Biogen Idec Inc | Homologe des nogo rezeptors |
| WO2003018631A2 (en) | 2001-08-27 | 2003-03-06 | Novartis Ag | Nogo receptor homologues and their use |
| EP1440091A1 (en) | 2001-10-22 | 2004-07-28 | Novartis AG | Nogo receptor homologues and their use |
| US20030113325A1 (en) * | 2001-12-03 | 2003-06-19 | Zhigang He | Reducing myelin-mediated inhibition of axon regeneration |
| US7309485B2 (en) * | 2001-12-03 | 2007-12-18 | Children's Medical Center Corporation | Reducing myelin-mediated inhibition of axon regeneration |
| EP1354892A1 (en) | 2002-04-19 | 2003-10-22 | Centre National De La Recherche Scientifique (Cnrs) | Peptides capable of inducing attraction of the axonal growth and their use for treating neurodegenerative diseases |
| US7745151B2 (en) * | 2002-08-02 | 2010-06-29 | Children's Medical Center Corporation | Methods of determining binding between Nogo receptor and p75 neurotrophin receptor |
| ES2346868T3 (es) | 2002-08-10 | 2010-10-21 | Yale University | Antagonistas de receptor nogo. |
| EA009643B1 (ru) * | 2003-04-16 | 2008-02-28 | Йейл Юниверсити | Лечение состояний, включающих амилоидные бляшки |
| BRPI0413426A (pt) | 2003-08-07 | 2006-10-17 | Biogen Idec Inc | antagonistas de receptor novo |
| US20080274112A1 (en) | 2003-08-07 | 2008-11-06 | Lee Daniel H S | Nogo Receptor Antagonists |
| KR20070052237A (ko) | 2004-01-30 | 2007-05-21 | 비오겐 아이덱 엠에이 아이엔씨. | 노고 수용체 길항제를 사용한, 도파민성 신경 퇴행을수반하는 상태의 치료법 |
| EP2276500A4 (en) | 2008-03-13 | 2015-03-04 | Univ Yale | REACTIVATION OF AXON GROWTH AND AXON RECOVERY IN CHRONIC REVERSE MARKET INJURIES |
-
2001
- 2001-10-06 US US09/972,599 patent/US7119165B2/en not_active Expired - Lifetime
-
2002
- 2002-10-04 WO PCT/US2002/032007 patent/WO2003031462A2/en not_active Ceased
- 2002-10-04 JP JP2003534444A patent/JP4383869B2/ja not_active Expired - Fee Related
- 2002-10-04 EP EP02800939A patent/EP1451337A4/en not_active Withdrawn
- 2002-10-04 AU AU2002334889A patent/AU2002334889B2/en not_active Ceased
- 2002-10-04 CA CA002461655A patent/CA2461655A1/en not_active Abandoned
-
2006
- 2006-09-06 US US11/516,024 patent/US20080219984A1/en not_active Abandoned
-
2010
- 2010-01-26 US US12/693,940 patent/US8394929B2/en not_active Expired - Fee Related
-
2013
- 2013-03-07 US US13/788,923 patent/US20130171157A1/en not_active Abandoned
- 2013-11-22 US US14/088,158 patent/US20140178392A1/en not_active Abandoned
-
2015
- 2015-07-13 US US14/798,125 patent/US20170174763A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005508165A5 (https=) | ||
| JP2003519481A5 (https=) | ||
| JP6807893B2 (ja) | α−シヌクレインを認識するヒト化抗体 | |
| KR101681910B1 (ko) | Rgm a 단백질에 대한 모노클로날 항체 및 이의 용도 | |
| ES2272093T5 (es) | Composiciones y métodos para incrementar la mineralización de la substancia ósea | |
| US9133272B2 (en) | Bispecific binding agents | |
| EP1181318B1 (en) | Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules | |
| DK2276778T3 (en) | Neurotrophic factor MANF as well as applications thereof | |
| AU2018225493B2 (en) | Early detection of glial cell activation in neurodegenerative or neuroinflammatory diseases | |
| KR101484025B1 (ko) | 염증성 질환의 치료를 위한 cxcl13 길항제 및 이의 용도 | |
| JP2022543387A5 (https=) | ||
| CA2872928C (en) | Use of semaphorin-4d binding molecules to promote neurogenesis following stroke | |
| HRP20180516T1 (hr) | Humanizirana protutijela specifična za protofibrilni oblik amiloidnog-beta peptida | |
| JP2009520691A5 (https=) | ||
| EA015166B1 (ru) | Иммуногенные пептиды склеростина (sost), индуцирующие образование специфических антител | |
| JP2019527194A5 (https=) | ||
| JP2008509658A5 (https=) | ||
| RS57315B1 (sr) | Humanizovana antitela koja prepoznaju alfa-sinuklein | |
| KR20240046648A (ko) | 항-il23 특이적 항체로 건선을 치료하는 안전하고 효과적인 방법 | |
| JP2008509152A5 (https=) | ||
| JP2020517262A5 (https=) | ||
| AU2023200728A1 (en) | Prevention or treatment method for peripheral neuropathy or pain accompanying disease in which peripheral neuropathy or astrocyte disorder is recognized | |
| JPH08504086A (ja) | 背側組織作用因子及び組成物 | |
| JP2012508027A5 (https=) | ||
| AU2010209273A1 (en) | Eotaxin-2 (CCL24) inhibitors in inflammatory, autoimmune, and cardiovascular disorders |